J. M. Brown & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.05M Sell
912
-30
-3% -$35.4K 0.6% 41
2026
Q2
$1.13M Buy
+942
New +$962K 0.65% 38

Other funds holding LLY

J. M. Brown & Associates's LLY Position: Q3 2026 in Review

J. M. Brown & Associates reduced its Eli Lilly (LLY) stake by 3.2% in Q3 2026, selling an estimated $35.4K and leaving 912 shares worth $1.05M. The position accounts for 0.6% of the portfolio, ranked #41.

J. M. Brown & Associates first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.13M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • J. M. Brown & Associates held 912 shares of Eli Lilly worth $1.05M as of Q3 2026.
  • J. M. Brown & Associates sold 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
  • Eli Lilly made up 0.6% of J. M. Brown & Associates's portfolio in Q3 2026, its #41 holding.
  • J. M. Brown & Associates first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • J. M. Brown & Associates's Eli Lilly position peaked at $1.13M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on J. M. Brown & Associates's 13F filing for Q3 2026, filed 12 Nov 2026.